Table: Stella Pharma - Q1 parent results

Stella Pharma

08/08/2023 07:20

Aug 8 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2023        Jun 30, 2022      Mar 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            61 mln              46 mln            269 mln    
                 (+33.3 pct)        (+500.0 pct)       (+17.4 pct)  
  Operating     loss 163 mln        loss 195 mln        loss 1.31   
  Recurring     loss 164 mln        loss 195 mln        loss 1.32   
  Net           loss 165 mln        loss 196 mln        loss 1.33   
  EPS           loss 5.44 yen       loss 6.86 yen    loss 44.28 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T